Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity

被引：1
|
作者：
Anthi, Anastasia [1 ,2 ]
Stagaki, Eleni [1 ]
Rallidis, Loukianos [1 ,3 ]
Konstantonis, Dimitrios [1 ,2 ]
Evangelopoulos, Maria-Eleftheria [4 ]
Voumvourakis, Konstantinos [5 ]
Armaganidis, Apostolos [1 ,2 ]
Orfanos, Stylianos E. [1 ,2 ]
机构：
[1] Attikon Hosp, Pulm Hypertens Clin, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Attikon Hosp, Dept Crit Care 2, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Attikon Hosp, Dept Cardiol 2, Athens, Greece
[4] Natl & Kapodistrian Univ Athens, Eginit Hosp, Dept Neurol, Demyelinating Dis Unit, Athens, Greece
[5] Natl & Kapodistrian Univ Athens, Attikon Hosp, Dept Neurol 2, Athens, Greece
来源：
ERJ OPEN RESEARCH | 2020年 / 6卷 / 01期
关键词：
D O I：
10.1183/23120541.00328-2019
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients
    Koudriavtseva, T.
    Plantone, D.
    Renna, R.
    Mandoj, C.
    Mainero, C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E309 - E309
  • [42] Interferon beta-1a long-term therapy related to pulmonary arterial hypertension in multiple sclerosis patients
    Fok, Anthony
    Williams, Trevor
    McLean, Catriona A.
    Butler, Ernest
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (11) : 1495 - 1498
  • [43] Managing the adverse effects of interferon-β therapy in multiple sclerosis
    Bayas, A
    Rieckmann, P
    DRUG SAFETY, 2000, 22 (02) : 149 - 159
  • [44] Improving Compliance with Interferon-β Therapy in Patients with Multiple Sclerosis
    Portaccio, Emilio
    Amato, Maria Pia
    CNS DRUGS, 2009, 23 (06) : 453 - 462
  • [45] Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients
    Tatiana Koudriavtseva
    Domenico Plantone
    Rosaria Renna
    Chiara Mandoj
    Diana Giannarelli
    Caterina Mainero
    Neurological Sciences, 2015, 36 : 2263 - 2268
  • [46] Managing the Adverse Effects of Interferon-β Therapy in Multiple Sclerosis
    Antonios Bayas
    Peter Rieckmann
    Drug Safety, 2000, 22 : 149 - 159
  • [47] Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients
    Koudriavtseva, Tatiana
    Plantone, Domenico
    Renna, Rosaria
    Mandoj, Chiara
    Giannarelli, Diana
    Mainero, Caterina
    NEUROLOGICAL SCIENCES, 2015, 36 (12) : 2263 - 2268
  • [48] Pulmonary arterial hypertension associated with systemic sclerosis
    Mathai, Stephen C.
    Hassoun, Paul M.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2011, 5 (02) : 267 - 279
  • [49] Interferon-β-1bPulmonary arterial hypertension: case report
    Reactions Weekly, 2009, 1264 (1) : 21 - 21
  • [50] Interferon-β-1aPulmonary arterial hypertension: case report
    Reactions Weekly, 2015, 1581 (1) : 190 - 190
12345